Depreciation of BIOMARIN PHARMACEUTICAL INC from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly and annual Depreciation in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIOMARIN PHARMACEUTICAL INC Depreciation for the quarter ending 31 Dec 2025 was $13,200,000, a 14% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC Depreciation for the twelve months ending 31 Dec 2025 was $48,500,000, a 4.1% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC annual Depreciation for 2025 was $48,500,000, a 4.1% increase from 2024.
  • BIOMARIN PHARMACEUTICAL INC annual Depreciation for 2024 was $46,600,000, a 16% increase from 2023.
  • BIOMARIN PHARMACEUTICAL INC annual Depreciation for 2023 was $40,300,000, a 4.4% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $48,500,000 $13,200,000 +$1,600,000 +14% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $46,900,000 $10,600,000 -$300,000 -2.8% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $47,200,000 $10,600,000 -$900,000 -7.8% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $48,100,000 $14,100,000 +$1,500,000 +12% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $46,600,000 $11,600,000 +$900,000 +8.4% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $45,700,000 $10,900,000 +$1,000,000 +10% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025 2025 Q3
Q2 2024 $44,700,000 $11,500,000 +$2,100,000 +22% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $42,600,000 $12,600,000 +$2,300,000 +22% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $40,300,000 $10,700,000 +$2,000,000 +23% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $38,300,000 $9,900,000 +$1,200,000 +14% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $37,100,000 $9,400,000 -$100,000 -1.1% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $37,200,000 $10,300,000 -$1,400,000 -12% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024 2024 Q1
Q4 2022 $38,600,000 $8,700,000 -$1,700,000 -16% 01 Oct 2022 31 Dec 2022 10-K 24 Feb 2025 2024 FY
Q3 2022 $40,300,000 $8,700,000 -$2,700,000 -24% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $43,000,000 $9,500,000 -$2,300,000 -19% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $45,300,000 $11,700,000 -$800,000 -6.4% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q4 2021 $46,100,000 $10,400,000 +$9,720,000 +1429% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $36,380,000 $11,400,000 +$300,000 +2.7% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $36,080,000 $11,800,000 +$2,100,000 +22% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $33,980,000 $12,500,000 -$9,020,000 -42% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $43,000,000 $680,000 +$16,047,000 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $26,953,000 $11,100,000 -$13,138,000 -54% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $40,091,000 $9,700,000 -$11,829,000 -55% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $51,920,000 $21,520,000 +$120,000 +0.56% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $51,800,000 $15,367,000 -$39,042,000 -165% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $90,842,000 $24,238,000 -$2,362,000 -8.9% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $93,204,000 $21,529,000 +$1,429,000 +7.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $91,775,000 $21,400,000 +$1,400,000 +7% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q4 2018 $90,375,000 $23,675,000 +$2,675,000 +13% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $87,700,000 $26,600,000 +$7,200,000 +37% 01 Jul 2018 30 Sep 2018 10-Q/A 04 Nov 2019 2019 Q3
Q2 2018 $80,500,000 $20,100,000 +$2,200,000 +12% 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019 2019 Q2
Q1 2018 $78,300,000 $20,000,000 +$2,500,000 +14% 01 Jan 2018 31 Mar 2018 10-Q 29 Apr 2019 2019 Q1
Q4 2017 $75,800,000 $21,000,000 +$3,900,000 +23% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $71,900,000 $19,400,000 -$3,800,000 -16% 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018 2018 Q3
Q2 2017 $75,700,000 $17,900,000 +$700,000 +4.1% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2017 $75,000,000 $17,500,000 +$1,800,000 +11% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018 2018 Q1
Q4 2016 $73,200,000 $17,100,000 +$3,500,000 +26% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $69,700,000 $23,200,000 +$10,500,000 +83% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 $59,200,000 $17,200,000 +$4,900,000 +40% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $54,300,000 $15,700,000 +$4,200,000 +37% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $50,100,000 $13,600,000 +$500,000 +3.8% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
Q3 2015 $49,600,000 $12,700,000 +$1,500,000 +13% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3
Q2 2015 $48,100,000 $12,300,000 +$1,900,000 +18% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $46,200,000 $11,500,000 +$1,900,000 +20% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q4 2014 $44,300,000 $13,100,000 +$3,900,000 +42% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $40,400,000 $11,200,000 +$2,000,000 +22% 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $38,400,000 $10,400,000 +$1,000,000 +11% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $37,400,000 $9,600,000 +$900,000 +10% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q4 2013 $36,500,000 $9,200,000 $0 0% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $36,500,000 $9,200,000 +$300,000 +3.4% 01 Jul 2013 30 Sep 2013 10-Q 28 Oct 2014 2014 Q3
Q2 2013 $36,200,000 $9,400,000 +$1,000,000 +12% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 $35,200,000 $8,700,000 +$300,000 +3.6% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q4 2012 $34,900,000 $9,200,000 +$200,000 +2.2% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $34,700,000 $8,900,000 +$800,000 +9.9% 01 Jul 2012 30 Sep 2012 10-Q 28 Oct 2013 2013 Q3
Q2 2012 $33,900,000 $8,400,000 +$1,000,000 +14% 01 Apr 2012 30 Jun 2012 10-Q 29 Jul 2013 2013 Q2
Q1 2012 $32,900,000 $8,400,000 +$1,000,000 +14% 01 Jan 2012 31 Mar 2012 10-Q 29 Apr 2013 2013 Q1
Q4 2011 $31,900,000 $9,000,000 01 Oct 2011 31 Dec 2011 10-K 26 Feb 2014 2013 FY
Q3 2011 $8,100,000 +$1,800,000 +29% 01 Jul 2011 30 Sep 2011 10-Q 29 Oct 2012 2012 Q3
Q2 2011 $7,400,000 +$2,200,000 +42% 01 Apr 2011 30 Jun 2011 10-Q 02 Aug 2012 2012 Q2
Q1 2011 $7,400,000 01 Jan 2011 31 Mar 2011 10-Q 30 Apr 2012 2012 Q1
Q3 2010 $6,300,000 01 Jul 2010 30 Sep 2010 10-Q 31 Oct 2011 2011 Q3
Q2 2010 $5,200,000 01 Apr 2010 30 Jun 2010 10-Q 01 Aug 2011 2011 Q2

BIOMARIN PHARMACEUTICAL INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $48,500,000 +$1,900,000 +4.1% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $46,600,000 +$6,300,000 +16% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $40,300,000 +$1,700,000 +4.4% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $38,600,000 -$7,500,000 -16% 01 Jan 2022 31 Dec 2022 10-K 24 Feb 2025 2024 FY
2021 $46,100,000 +$3,100,000 +7.2% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $43,000,000 -$8,800,000 -17% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $51,800,000 -$38,575,000 -43% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $90,375,000 +$14,575,000 +19% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $75,800,000 +$2,600,000 +3.6% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $73,200,000 +$23,100,000 +46% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $50,100,000 +$5,800,000 +13% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $44,300,000 +$7,800,000 +21% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
2013 $36,500,000 +$1,600,000 +4.6% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $34,900,000 +$3,000,000 +9.4% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $31,900,000 +$8,600,000 +37% 01 Jan 2011 31 Dec 2011 10-K 26 Feb 2014 2013 FY
2010 $23,300,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.